Indication

Pernicious anemia

Pernicious anemia is an autoimmune hematologic disorder characterized by the impaired intestinal absorption of dietary vitamin B12 (cobalamin), leading to megaloblastic anemia. Read more about Pernicious anemia

30 drugs 28 manufacturers

Advertisement

Drugs that treat it

Common Pernicious anemia therapies.

Showing 19–27 of 30 drugs

Filter & compare in the drug finder →Opens the drug finder with Pernicious anemia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Pernicious anemia.

Pernicious anemia is an autoimmune hematologic disorder characterized by the impaired intestinal absorption of dietary vitamin B12 (cobalamin), leading to megaloblastic anemia.

Primarily affecting older adults and individuals with autoimmune predispositions, the condition arises from autoimmune gastritis marked by autoantibodies against gastric parietal cells and intrinsic factor.

The resulting destruction of parietal cells causes intrinsic factor deficiency and achlorhydria, preventing the formation of intrinsic factor-cobalamin complexes required for ileal uptake.

Clinical and pathophysiologic hallmarks include defective erythroid DNA synthesis leading to macrocytic anemia, systemic manifestations of fatigue and glossitis, and potentially irreversible neurological sequelae such as peripheral neuropathy and subacute combined degeneration of the spinal cord.

Personalize your experience

Follow Pernicious anemia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it